Biosensors for natriuretic peptides in cardiovascular diseases. A review
Copyright © 2023. Published by Elsevier Inc..
Heart failure (HF) is a complex clinical syndrome associated with high rates of morbidity and mortality. Over the years, it has been crucial to find accurate biomarkers capable of doing a precise monitor of HF and provide an early diagnosis. Of these, it has been established an important role of natriuretic peptides in HF assessment. Moreover, the development of biosensors has been garnering interest as new diagnostic medical tools. In this review we first provide a general overview of HF, its pathogenesis, and diagnostic features. We then discuss the role of natriuretic peptides in heart failure by characterizing them and point out their potential as biomarkers. Finally, we adress the evolution of biosensors development and the available natriuretic peptides biosensors for disease monitoring.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:49 |
---|---|
Enthalten in: |
Current problems in cardiology - 49(2024), 1 Pt C vom: 31. Jan., Seite 102180 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Sousa, Mariana P [VerfasserIn] |
---|
Links: |
---|
Themen: |
Biomarker |
---|
Anmerkungen: |
Date Completed 16.12.2023 Date Revised 31.01.2024 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1016/j.cpcardiol.2023.102180 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM363991050 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM363991050 | ||
003 | DE-627 | ||
005 | 20240131231933.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.cpcardiol.2023.102180 |2 doi | |
028 | 5 | 2 | |a pubmed24n1276.xml |
035 | |a (DE-627)NLM363991050 | ||
035 | |a (NLM)37907188 | ||
035 | |a (PII)S0146-2806(23)00597-2 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Sousa, Mariana P |e verfasserin |4 aut | |
245 | 1 | 0 | |a Biosensors for natriuretic peptides in cardiovascular diseases. A review |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 16.12.2023 | ||
500 | |a Date Revised 31.01.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2023. Published by Elsevier Inc. | ||
520 | |a Heart failure (HF) is a complex clinical syndrome associated with high rates of morbidity and mortality. Over the years, it has been crucial to find accurate biomarkers capable of doing a precise monitor of HF and provide an early diagnosis. Of these, it has been established an important role of natriuretic peptides in HF assessment. Moreover, the development of biosensors has been garnering interest as new diagnostic medical tools. In this review we first provide a general overview of HF, its pathogenesis, and diagnostic features. We then discuss the role of natriuretic peptides in heart failure by characterizing them and point out their potential as biomarkers. Finally, we adress the evolution of biosensors development and the available natriuretic peptides biosensors for disease monitoring | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Review | |
650 | 4 | |a Biomarker | |
650 | 4 | |a Biosensor | |
650 | 4 | |a Heart failure | |
650 | 4 | |a Natriuretic peptide | |
650 | 7 | |a Natriuretic Peptides |2 NLM | |
650 | 7 | |a Biomarkers |2 NLM | |
700 | 1 | |a Bettencourt, Paulo |e verfasserin |4 aut | |
700 | 1 | |a Brás-Silva, Carmen |e verfasserin |4 aut | |
700 | 1 | |a Pereira, Claudia |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Current problems in cardiology |d 1993 |g 49(2024), 1 Pt C vom: 31. Jan., Seite 102180 |w (DE-627)NLM000219622 |x 1535-6280 |7 nnns |
773 | 1 | 8 | |g volume:49 |g year:2024 |g number:1 Pt C |g day:31 |g month:01 |g pages:102180 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.cpcardiol.2023.102180 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 49 |j 2024 |e 1 Pt C |b 31 |c 01 |h 102180 |